Jack Nielsen, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 134,400 shares at $57.08 ($7.7M) on 2022-11-21, disclosed to the SEC on 2022-11-22.
Open-market sale of $7.7M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.00 | 20,800 | $1.2M | 15.4% |
| 2 | $57.08 | 24,898 | $1.4M | 18.4% |
| 3 | $57.08 | 24,898 | $1.4M | 18.4% |
| 4 | $57.60 | 31,902 | $1.8M | 23.9% |
| 5 | $57.60 | 31,902 | $1.8M | 23.9% |
| Total | $57.31 avg | 134,400 |
| $7.7M |
| 100% |
| Filing → |
| HRMY | SELL | 2022-12-01 | $11.4M | — | Filing → |
| HRMY | SELL | 2022-11-15 | $16.1M | — | Filing → |
| HRMY | SELL | 2022-08-08 | $13.2M | — | Filing → |